Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Payables (2020 - 2025)

Historic Payables for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $11.1 million.

  • PROCEPT BioRobotics' Payables fell 2631.23% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.1 million, marking a year-over-year decrease of 2631.23%. This contributed to the annual value of $10.0 million for FY2024, which is 2568.34% down from last year.
  • Latest data reveals that PROCEPT BioRobotics reported Payables of $11.1 million as of Q3 2025, which was down 2631.23% from $11.8 million recorded in Q2 2025.
  • PROCEPT BioRobotics' Payables' 5-year high stood at $15.1 million during Q3 2024, with a 5-year trough of $2.0 million in Q4 2021.
  • For the 5-year period, PROCEPT BioRobotics' Payables averaged around $9.3 million, with its median value being $10.0 million (2023).
  • Per our database at Business Quant, PROCEPT BioRobotics' Payables soared by 36283.88% in 2022 and then crashed by 2631.23% in 2025.
  • Over the past 5 years, PROCEPT BioRobotics' Payables (Quarter) stood at $2.0 million in 2021, then skyrocketed by 362.84% to $9.4 million in 2022, then soared by 43.74% to $13.5 million in 2023, then fell by 25.68% to $10.0 million in 2024, then grew by 10.83% to $11.1 million in 2025.
  • Its last three reported values are $11.1 million in Q3 2025, $11.8 million for Q2 2025, and $14.8 million during Q1 2025.